Cholangiocarcinoma is a relatively rare cancer of the biliary ducts that is highly refractory to treatment. The factors that drive cholangiocarcinoma are poorly understood, though chronic liver fluke infection is a risk factor for disease. In this issue of the
David M. Virshup
A mutation-prone ubiquitin ligase module regulates cellular sensitivity to WNTs.